A Bioavailability Study of GSK1363089 in Subjects With Solid Tumors

Status:
Completed

Trial end date:
2009-06-24

Target enrollment:

Participant gender:

Study to compare 2 different chemical forms of GSK1363089.

Phase 1

GlaxoSmithKline